Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
---|
05/22/2002 | EP1206487A2 Notch receptor ligands and uses thereof |
05/22/2002 | EP1206486A2 Growth-enhancing media for mycobacteria |
05/22/2002 | EP1206479A1 A polynucleotide encoding a human junctional adhesion protein (jam-2) |
05/22/2002 | EP1206477A1 Cloning of the streptomyces avermitilis genes for glycosylation of avermectin aglycones |
05/22/2002 | EP1206416A1 Hybrid chemical and biological process for decontaminating sludge from municipal sewage |
05/22/2002 | EP1206233A2 Serine proteases |
05/22/2002 | EP1107996B1 HUMAN ANTI-FACTOR IX/IXa ANTIBODIES |
05/22/2002 | EP0949866B1 Plant immunization compositions |
05/22/2002 | EP0846184B1 Solvent extraction of polyhydroxyalkanoates from biomass facilitated by the use of a marginal nonsolvent for pha |
05/22/2002 | CN1350586A Process for the fermentative preparation of L-amino acids with amplification of the GND gene |
05/22/2002 | CN1350585A i(Neisseria meningitidis) polypeptide BASBO52 |
05/22/2002 | CN1350584A Process for producing recombinant insulain from novel fused protein |
05/22/2002 | CN1350579A 葡萄糖脱氢酶 Glucose dehydrogenase |
05/22/2002 | CN1350541A Plant activator, process for producing the same, actwation method, activity promoter and method for applying the promoter |
05/22/2002 | CN1350462A Lactobacillus strains capable of preventing diarrhoea caused by pathogenic bacteria and rotaviruses |
05/22/2002 | CN1350461A Lactobacillus strain preventing diarrhoea pathogenic bacteria |
05/22/2002 | CN1350460A Lactic acid bacteria strains capable of preventing diarrhoea |
05/22/2002 | CN1350060A Phytase gene and its cloning |
05/22/2002 | CN1350058A Method of breeding strain for soaking ore |
05/22/2002 | CN1350057A Composite ferment strain and its production process |
05/22/2002 | CN1349824A Production process of healthy soybean oral liquid |
05/22/2002 | CN1085249C production of variant nisin |
05/21/2002 | US6392028 Functional DNA clone for hepatitis C virus (HCV) and uses thereof |
05/21/2002 | US6392024 Nucleotide sequences coding freeze resistant polypeptide; for use in food processing and organ transplants |
05/21/2002 | US6392023 Nucleotide sequences which codes preferential polypeptide for use in serodiagnostics and vaccine development |
05/21/2002 | US6392018 Polypeptides for use in the treatment of pathologies associated with inflammatory respone, nervous system disorders and leukemias; for use as a molecular weight control; for use in foods |
05/21/2002 | US6392016 Preferential polypeptide for use in the diagnosis and treatment of tumors; antiproliferative agents |
05/21/2002 | US6392014 Cloning of gene encoding the GP28.5 protein of Toxoplasma gondii; peptide fragments of said protein and their applications |
05/21/2002 | US6391853 Human tissue inhibitor of metalloproteinase-4 |
05/21/2002 | US6391642 Transformation-associated recombination cloning |
05/21/2002 | US6391640 Methods and compositions for cellular and metabolic engineering |
05/21/2002 | US6391632 Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis |
05/21/2002 | US6391626 Nutrient broth for the detection of bacteria |
05/21/2002 | US6391619 Methods and compositions for suppressing growth of algae |
05/21/2002 | US6391618 Microorganism culture for use in bioremediation and waste treatment |
05/21/2002 | US6391617 Yeast compositions for converting bio-available nitrogen in a culture medium to intracellular nitrogen |
05/21/2002 | US6391615 Isolate of Antrodia camphorata process for producing a culture of the same and product obtained thereby |
05/21/2002 | US6391613 Motor proteins and methods for their use |
05/21/2002 | US6391606 Peptides; for use in the develoment of human diagnostic and therapeutic agents |
05/21/2002 | US6391605 Modified phytases |
05/21/2002 | US6391604 Thermostable enzyme having phosphatidylethanolamine N-methyltransferase activity |
05/21/2002 | US6391603 Genes of purine biosynthesis from Ashbya gossypii and the use thereof in microbial riboflavin synthesis |
05/21/2002 | US6391601 Transport protein for use in the treatment of cell proliferation defects, cancer, hyperplasias, restenosis, cardiovascular, immune and inflammatory disorders |
05/21/2002 | US6391600 PcrA helicase |
05/21/2002 | US6391595 Transferase and amylase, process for producing the enzymes, use thereof, and gene coding for the same |
05/21/2002 | US6391594 Generating nucleotide sequence encoding genetically engineered polyketide synthase; obtain nucleotide sequences, insert into expression vectors, transform cells, recover enzymatic polypeptide |
05/21/2002 | US6391590 Generation hybrid polypeptide; obtain cell, transform cells with expression vector, recover hybrid polypeptide |
05/21/2002 | US6391588 Nucleotides squences coding preferential amino acid sequences for use in treating bone disorder in mammals |
05/21/2002 | US6391585 Plasmid for use as tool in generation of genetic engineering heterologous proteins |
05/21/2002 | US6391580 Ras proteins |
05/21/2002 | US6391579 Nucleotide sequences coding transport protein for use in the treatment of thyroid defects |
05/21/2002 | US6391574 AFC1 and RCE1: isoprenylated CAAX processing enzymes |
05/21/2002 | US6391569 Method to detect Dirofilaria immitis infection |
05/21/2002 | US6391565 Methods of detecting growth differentiation factor-3 |
05/21/2002 | US6391553 Analyzing level of gene expression of epsilon 4 or epsilon 2 alleles of apolipoprotein e; mutation in consensus sequence binding a transcription factor and either increase in epsilon 4 or decrease in epsilon 2 indicate disease |
05/21/2002 | US6391552 Enhancing transfection efficiency of vectors by recursive recombination |
05/21/2002 | US6391547 Microbial β-glucuronidase genes, gene products and uses thereof |
05/21/2002 | US6391543 Screening sample for preferential nucleotide sequences; incubate sample with nucleotide sequences, monitor sample for signal indicating bound nucleotide sequences |
05/21/2002 | US6391541 Uses cartridge for efficient processing of large sample volumes foraccurate detection of low concentration analytes |
05/21/2002 | US6391298 Method of using PON-1 to decrease atheroma formation |
05/21/2002 | US6391285 Antimicrobial polypeptide and methods of use |
05/21/2002 | US6391238 Culture of algae, curing, molding and floating |
05/21/2002 | CA2183241C Yeast strains and modified albumins |
05/21/2002 | CA2070788C Process for producing spagyric essences from plants |
05/21/2002 | CA1341361C Human erythropoietin gene: high level expression in stably transfected mammalian cells |
05/16/2002 | WO2002038805A2 Eukaryotic cell division genes and their use in diagnosis and treatment of proliferative diseases |
05/16/2002 | WO2002038791A1 Method for producing lycopene-containing biomass and method for the production of crystalline lycopene from said biomass |
05/16/2002 | WO2002038788A2 Process for the fermentative preparation of l-amino acids using coryneform bacteria |
05/16/2002 | WO2002038774A2 Bacterial phytases and method for producing same |
05/16/2002 | WO2002038772A1 Nucleotide sequences which code for the nadc gene |
05/16/2002 | WO2002038770A1 Yeast derived vaccine against ipnv |
05/16/2002 | WO2002038766A2 Human tumor necrosis factor receptor |
05/16/2002 | WO2002038744A2 Proteases |
05/16/2002 | WO2002038740A1 Recombinant zymomonas mobilis with improved xylose utilization |
05/16/2002 | WO2002038739A1 Bacterial expression systems |
05/16/2002 | WO2002038733A2 A selectable genetic marker for use in pasteurellaceae species |
05/16/2002 | WO2002038732A2 Human testis specific serine/threonine kinase |
05/16/2002 | WO2002038730A2 Novel human potassium channel beta subunit |
05/16/2002 | WO2002038609A2 Apolipoprotein conjugates |
05/16/2002 | WO2002038607A2 A 'bach' g protein coupled receptor polypeptide and polynucleotide encoding this receptor |
05/16/2002 | WO2002038600A2 C. elegans genes involved in viability and/or reproduction and uses thereof |
05/16/2002 | WO2002038597A2 Genomic fragment of streptococcus suis and clinical uses thereof |
05/16/2002 | WO2002038594A1 Novel therapeutic compositions for treating infection by lawsonia spp |
05/16/2002 | WO2002037961A2 Methods and compositions for the control of coccidiosis |
05/16/2002 | WO2002017902A8 Gene conferring resistance to the antibacterial 4,5-dihydroxy-2-cyclopenten-1-one (dhcp), the protein encoded by same, and applications thereof |
05/16/2002 | WO2002006502A3 Adenovirus vectors comprising introns |
05/16/2002 | WO2002004512A3 Purification of human troponin i |
05/16/2002 | WO2002000909A3 Methods for improving cell growth and alcohol production during fermentation |
05/16/2002 | WO2001098435A3 Avalon biopreparation for removing petrol and petrol products from environmental sites and method for producing said biopreparation |
05/16/2002 | WO2001098335A3 Transgenic algae for delivering antigens to an animal |
05/16/2002 | WO2001096593A3 Novel motor proteins and methods for their use |
05/16/2002 | WO2001092496A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
05/16/2002 | WO2001085933A3 Plakoglobin interacting proteins |
05/16/2002 | WO2001081599A3 Protection against environmental toxicity through manipulation of the processing of messenger rna precursors |
05/16/2002 | WO2001081405A3 Methods and compositions for the prevention and treatment of anemia |
05/16/2002 | WO2001080810A3 Chondroitin synthase gene and methods of making and using same |
05/16/2002 | WO2001079492A3 Lipid binding protein 3 |
05/16/2002 | WO2001073083B1 Promoter sequence of 3-phosphoglycerate kinase gene 1 of rhizopus oryzae and its use |
05/16/2002 | WO2001068893A3 Soapstock hydrolysis and acidulation by acidogenic bacteria |
05/16/2002 | WO2001048163A3 Dioxygenases catalyzing the asymetric cleavage of beta-carotene |